Maitansine

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Maitansine (INN), or maytansine (USAN), is a cytotoxic agent. It inhibits the assembly of microtubules by binding to tubulin at the rhizoxin binding site. The maytansine binding site and binding mode has been characterized. It is a macrolide of the ansamycin type and can be isolated from plants of the genus Maytenus.

Maitansine (INN), or maytansine (USAN), is a cytotoxic agent. It inhibits the assembly of microtubules by binding to tubulin at the rhizoxin binding site. The maytansine binding site and binding mode has been characterized. It is a macrolide of the ansamycin type and can be isolated from plants of the genus Maytenus.

Maytansinoids

Derivatives of maitansine are known as maytansinoids. Some are being investigated as the cytotoxic component of antibody-drug conjugates for cancer treatment, and the antibody-drug conjugate trastuzumab emtansine is an approved drug for the treatment of certain kinds of breast cancer in the EU and in the US. Examples of maytansinoids are: Ansamitocin Mertansine / emtansine (DM1) Ravtansine / soravtansine (DM4)

See also

ImmunoGen, developer of maytansinoid based drugs

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1294390097 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.